Search
for
Sort by
Research 91–120 of 1000+
- Alopecia areata following COVID-19 vaccine: a systematic review
- SDRIFE Induced by Tofacitinib
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Ann Robinson’s research reviews —12 May 2022
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Alopecia Universalis: Never Give Up?
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- When hair dig into the brain, JAKi , may help!
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Alopecia in general medicine
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib
- BH04 Growing interest: a survey of low-dose oral minoxidil prescribing for hair loss
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases